Pharmaceutical Technology E-Alert:
Having trouble viewing this e-mail? Click here.
You are subscribed to %%list.name%% as %%emailaddr%%.
Unsubscribe from this list.
  Pharmaceutical Technology Europe E-Alert
 
November 13, 2009
IN THIS ISSUE
Boosting manufacturing
New Swedish company
EU strategy for H1N1
PTE on LinkedIn
More...

UK backs continuous processing
A consortium led by GlaxoSmithKline (UK) intends to deliver a "step change improvement" in pharmaceutical tablet manufacturing in the UK by "substantially" increasing the country's manufacturing efficiency. More...

New specialty pharma company formed in Sweden
A new pharmaceutical company with a focus on rare diseases has been formed in Sweden following the merger of the Swedish companies Biovitrum and Swedish Orphan. More...

EU issues strategy for Influenza A (H1N1) vaccine benefit-risk monitoring
The European Medicines Agency, the European Centre for Disease Prevention and Control, and the Heads of Medicines Agencies have issued a European strategy for H1N1 vaccine benefit-risk monitoring. More...

Join PTE on LinkedIn!
Join Pharmaceutical Technology Europe's group on LinkedIn. More...

Novartis updates vaccine progress; acquires Chinese vaccine manufacturer
German regulatory authorities have approved Novartis’ adjuvanted cell culture-based H1N1 2009 monovalent vaccine, Celtura. The company has also said it will acquire a stake in the Chinese vaccines company Zhejiang Tianyuan Bio-Pharmaceutical. More...

PhRMA reacts to house healthcare-reform bill
The Pharmaceutical Research and Manufacturers of America (PhRMA) has expressed its disappointment with the US House of Representatives’s healthcare-reform bill. More...

Are you following us?
Pharmaceutical Technology Europe is on Twitter. More...

Event Profile
UBMI
  CPhI India 2009
Date: 1-3 December 2009
Venue: Bombay Exhibition Centre, Mumbai, India

Global downturn, patent expirations, dearth of product innovation pipelines… The global pharmaceutical landscape is changing, and you have to position yourself in this challenging environment.

Read more...

Product Profile
Shimadzu
  prominence TOX.I.S.
(HPLC/PDA for identification of drugs in human urine)


Acute intoxications require immediate reaction – based on reliable analysis. Shimadzu’s TOX.I.S. system delivers fast results applying automated process as well as universal sample pre-treatment and identification methods.

Read more...

On Demand Webcast
Just Systems
  Complex Documents in the Pharmaceutical Industry Made Easy

Documents are created just about everywhere in the pharmaceutical industry. To manage interrelated documents, collaboratively created and updated, versioned and published to different targets can often turn into a nightmare. With XML authoring, recurrent tasks such as applying repetitive changes to similar documents or assuring quality for cross-referencing, can finally be automated.

Read more...

Key Topic Updates
November events
Active Pharmaceutical Ingredients (18–20 November | Italy)
Dissolution Testing (24–25 November | UK)
Packaging & GMP (24–25 November | UK)
More events
 
Latest industry leader Q&As
Barcode technology addresses the counterfeit dilemma
A novel drug detection technology
Is EU pharma ready for Braille embossing?
More Q&As
Latest articles
The pharmaceutical packaging market
Case study: printing powders with Sticky Web technology
Regulatory challenges of inhaler testing
More latest articles

Key Topic Updates

Survey
Are current aseptic techniques/technologies adequate to ensure patient/personnel safety?
  Yes 50%
  No 30%
  Not Sure 20%

This week we would like to know...

What are your thoughts on innovation and the next generation?
Click here to vote

Contact Us
Click here to contact editorial.

Click here to contact sales.

You are subscribed to %%list.name%% as %%emailaddr%%. To unsubscribe from this list click here.

To ensure delivery to your Inbox, please add %%email.list%% to your address book. If you need help doing this, click here.

Advanstar Communications provides certain customer contact data (such as customers' names, addresses, phone numbers and e-mail addresses) to third parties who wish to promote relevant products, services and other opportunities which may be of interest to you. If you do not want Advanstar Communications to make your contact information available to third parties for marketing purposes, please contact us by emailing magazines@superfill.comor by mail at Advanstar Communications, Advanstar House, Park West, Sealand Road, Chester, CH1 4RN, UK.